More than 1000 drugs have been tested, with over 400 demonstrating efficacy in animal models of stroke; furthermore, substantial efforts have been made to explore preventive methods to reduce the morbidity and mortality of stroke [7], resulting in the development of recombinant tissue plasminogen activator (r-TPA), aspirin and heparin [3,5]. Here, PLAT is linked to stroke disorder.